SciSparc Ltd.
$4.23
▼
-3.28%
2026-04-21 09:34:01
scisparc.com
NCM: SPRC
Explore SciSparc Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.5 M
Current Price
$4.23
52W High / Low
$94.5 / $2.98
Stock P/E
—
Book Value
$142.32
Dividend Yield
—
ROCE
-80.93%
ROE
-12.81%
Face Value
—
EPS
$3,156.52
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
2
Beta
1.33
Debt / Equity
0.01
Current Ratio
5.36
Quick Ratio
5.28
Forward P/E
—
Price / Sales
1.36
Enterprise Value
—
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Annexon, Inc. | $6.43 | — | $1.05 B | — | -92.11% | -81.9% | $7.18 / $1.4 | $1.42 |
| 2. | MiNK Therapeutics, Inc. | $12.82 | — | $63.66 M | — | 859.68% | 57.3% | $76 / $6.34 | $-3.02 |
| 3. | Madrigal Pharmaceuticals, Inc. | $535 | — | $12.26 B | — | -31.61% | -42.49% | $615 / $265 | $26.39 |
| 4. | Whitehawk Therapeutics, Inc. | $4.23 | — | $193.98 M | — | -83.93% | -21.82% | $4.48 / $1.39 | $2.89 |
| 5. | Alnylam Pharmaceuticals, Inc. | $310.49 | 133.51 | $41.46 B | — | 14.33% | 73.28% | $495.55 / $228.28 | $5.96 |
| 6. | Corbus Pharmaceuticals Holdings, Inc. | $10.62 | — | $188.36 M | — | -57.84% | -54.18% | $20.56 / $5.75 | $8.38 |
| 7. | Immunovant, Inc. | $28.53 | — | $5.81 B | — | -61.93% | -69.35% | $29.48 / $13.36 | $4.85 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 1.31 M | 2.88 M | 1.35 M | 0 M |
| Operating Profit | -7.24 M | -5.77 M | -8.29 M | -5.77 M |
| Net Profit | -6.28 M | -5.12 M | -2.59 M | -5.79 M |
| EPS in Rs | -11.11 | -9.06 | -4.58 | -10.24 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 10.35 M | 11.18 M | 10.61 M | 9.92 M |
| Total Liabilities | 1.41 M | 1.59 M | 4.16 M | 1.77 M |
| Equity | 8.15 M | 7.61 M | 6.45 M | 8.14 M |
| Current Assets | 7.5 M | 6.45 M | 4.51 M | 9.82 M |
| Current Liabilities | 1.4 M | 1.57 M | 4.16 M | 1.76 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -5.1 M | -5.89 M | -7.92 M | -5.06 M |
| Investing CF | -1.62 M | -4.09 M | -7.08 M | -0.07 M |
| Financing CF | 6.19 M | 8.48 M | 11.7 M | 10.06 M |
| Free CF | -5.1 M | -5.89 M | -12.79 M | -5.1 M |
| Capex | — | — | -4.87 M | -0.04 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -54.64% | 113.73% | — | — |
| Earnings Growth % | -22.69% | -97.61% | 55.23% | — |
| Profit Margin % | -481.16% | -177.91% | -192.43% | — |
| Operating Margin % | -554.52% | -200.52% | -615.22% | — |
| Gross Margin % | 38.74% | 76.28% | 76.1% | — |
| EBITDA Margin % | -534% | -184.58% | -174.83% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-03-04 | 1:0.111111 |
| 2025-07-03 | 1:0.047619 |
| 2023-09-28 | 1:0.0384615 |